Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes [Phase 4]
Phase 4 trial comparing vildagliptin to pioglitazone added to metformin in type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.
This completed clinical trial investigates weight trajectory in patients with Type 2 Diabetes Mellitus who are new users of sulfonylureas ad…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts [NA]
A completed clinical trial evaluating lipid-lowering with highly potent statins in patients with hypercholesterolemia and type 2 diabetes, w…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function [Phase 4]
Phase 4 trial assessing the effects of pioglitazone and exenatide on body weight and beta cell function in individuals with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Prevalence and Risk Factors of Erectile Dysfunction in Type 2 Diabetic Patients
This completed clinical trial reports on the prevalence and risk factors of erectile dysfunction in men with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients [NA]
A completed clinical trial investigated whether omega-3 fatty acids affect insulin sensitivity in Chinese patients with type 2 diabetes and …
-
FDA approval · 2015-03-16FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a pioglitazone and glimepiride combination product developed by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) [Phase 4]
A Phase 4 trial comparing gemigliptin to sitagliptin or glimepiride, each added to metformin, assessing glucose variability in type 2 diabet…
-
FDA approval · 2015-03-12FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approves a supplemental application for AFREZZA (insulin human) from MannKind Corporation. The approval relates to labeling/indication e…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Behavioral Lifestyle Intervention Study (BLIS) in Patients With Type 2 Diabetes in UAE: A Randomized Controlled Trial in Real Life Setting [NA]
A randomized controlled trial in the United Arab Emirates evaluating a Behavioral Lifestyle Intervention Study (BLIS) for adults with type 2…
-
CLINICAL_TRIALS research · 2015-03-12Clinical Trial Update: Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp [Phase 4]
This clinical trial update describes a Phase 4 study investigating whether DPP-4 inhibitors influence beta-cell function in type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating Aloe vera in chronic periodontitis with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Maximising the Taste and Health Value of Plant Food Products [NA]
Clinical trial update noting completion of a study from Aarhus University Hospital evaluating plant-based foods for taste and health value i…
-
CLINICAL_TRIALS withdrawal · 2015-03-11Clinical Trial Update: Intensive Lifestyle Intervention for Type 2 Diabetics: The KP TLC Pilot [NA]
The KP TLC Pilot trial studying intensive lifestyle intervention for Type 2 Diabetes was withdrawn.
-
FDA approval · 2015-03-10FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients [Phase 4]
Phase 4 trial evaluating short-term intensive insulin sequential exenatide therapy in newly diagnosed Type 2 diabetes mellitus has completed…
-
FDA approval · 2015-03-09FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for TRULICITY (dulaglutide) from Eli Lilly and Company.
-
FDA approval · 2015-03-09FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide from Teva Pharmaceuticals USA, Inc. The action indicates regulatory approval for pot…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Effects of Low- or High-glycemic Index Diets on Metabolic and Inflammatory Responses in Diabetics [NA]
This is a completed clinical trial evaluating how low- and high-glycemic index diets affect metabolic and inflammatory responses in people w…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Optimized Glycemic Control in Heart Failure Patients With DM2:"Effect on Left Ventricular Function and Skeletal Muscle" [Phase 2]
Phase 2 clinical trial evaluating whether optimized glycemic control improves left ventricular function and skeletal muscle in patients with…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients [Phase 2]
A Phase 2 trial evaluating ACZ885 (canakinumab) for safety and vascular outcomes in patients with atherosclerosis and either type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Ehealth: Second Life Impacts Diabetes Education & Self-Management [NA]
A completed clinical trial sponsored by Duke University evaluating a Second Life-based eHealth education and self-management program for typ…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Promoting Physical Activity Among Patients With Type 2 Diabetes [Phase 2, Phase 3]
Clinical trial update reporting Phase 2 and Phase 3 studies assessing interventions to promote increased physical activity in adults with Ty…
-
FDA label_change · 2015-03-03FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental labeling application for APIDRA (insulin glulisine) from Sanofi-aventis U.S. LLC, updating the product labeling.
-
FDA approval · 2015-03-03FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.